Leading NHS suppliers highlighted in shortlist for new HSJ awards
January 16, 2018 |
The finalists for the first HSJ Healthcare Partnership Awards have been announced. The awards serve to recognise and celebrate those suppliers who work in partnerships with the NHS to drive efficiency and improve patient care.
The awards have 12 categories which embrace most healthcare supply markets. These include: clinical support services, medical technology, healthcare analytics, consultancy, legal services, and property/estates.
The winners will be announced at the Royal College of Physicians on 8 March.
Entrants demonstrated outstanding commitment to working in collaboration with the NHS through cutting edge innovation and service provision. The judges were impressed with the high standard of entries, testifying to the clear achievement of any shortlisted organisation.
HSJ editor Alastair McLellan said: “Hundreds of organisations are working behind the scenes to help the NHS improve its services and facilities, and deliver better care for patients. Yet their contribution is often unseen.
“Our aim was to change that through the HSJ Healthcare Partnership Awards, which have given businesses the chance to showcase innovative projects and long term support programmes that are really making a difference to the NHS in these challenging economic times.”
HSJ Healthcare Partnership Awards 2018 shortlist Legal services provider
- Hempsons
- Cripps LLP
- Bevan Brittan LLP
- Hill Dickinson LLP
- Ward Hadaway
Consultancy/consultant
- LTS Health
- Carnall Farrar
- Four Eyes Insight
- PA Consulting Group
- GE Healthcare Finnamore
- NHS Transformation Unit
- North of England Commissioning Support
Recruitment services provider
- Bank Partners (part of the Independent Clinical Services Group)
- Medical Staffing Ltd
- de Poel health+care
- Capita
- Remedium Partners
Property and estates management service
- Medtronic Integrated Health Solutions
- Plan B Solutions
- Serco
- Clugston Construction
- Central London Community Healthcare Trust partnership
Facilities management supplier
- London Ambulance Service Trust/Interserve
- Compass Group UK&I Healthcare
- Sodexo
- Clugston Construction
Pharmaceutical partnership with the NHS
- Merck, Sharp and Dohme
- Novartis Oncology
- Novartis Oncology Market Access
- Novo Nordisk and Diabetes UK
- Novo Nordisk
- Amgen and UCLH Cancer Collaborative
- Bayer
- Sandoz UK
- Napp Pharmaceuticals
- AstraZeneca UKMC
- Pharmacy Management
Healthcare provider to the NHS
- 18 Week Support
- Circle Health
- Siemens Healthineers
Innovation in medical technology
- Entec Health
- Endomagnetics
- Philips
- Intercity Technology
- Orion Health and Temple Street Children’s University Hospital
- Hamilton Medical AG
- NeoTract Inc
- Amplitude Clinical Outcomes
- Bruin Biometrics
Workforce innovation
- Megalist
- Membership Engagement Services
- Eastern Academic Health Science Network/Saberr/Hertfordshire Partnership University Foundation Trust
- SARD JV
- Hicom
- Content Guru
- CMP Resolutions
- Urgo Medical
- Liquid Bronze
- ESRconnect
Provider of healthcare analytics
- Carnall Farrar
- Carnall Farrar
- Membership Engagement Services
Clinical support service
- Urgo Medical
- Home Group
Procurement or support service
- Leaseguard Group
- de Poel health+care
ENDS
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare launches new platform to map the formulary landscape
Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.
Wilmington Healthcare appoints new Head of Digital
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...
How has the pandemic reshaped the NHS in 2020?
Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
How can pharma align its brand strategy with the NHS Reset?
Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
White paper helps industry navigate new NHS roadmap
New report shows how pharma can support the NHS in the Covid-19 recovery era
Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Covid-19: how is it impacting on the NHS Long-term Plan?
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it